For Immediate Release:
January 12, 2010
SIMULATIONS PLUS SETS DATE FOR 1st QUARTER FISCAL YEAR 2010 earnings release and conference call
Conference Call to be on Wednesday, January 13, at 4:15 PM EST
LANCASTER, CA, January 12, 2010
– Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of software and consulting services for pharmaceutical R&D and environmental toxicology, announced that it expects to file its Form 10-Q quarterly report with the Securities and Exchange Commission on Tuesday, January 12, for the first quarter of its 2010 fiscal year ended November 30, 2009. Chairman and CEO Walt Woltosz will host a conference call and webinar to discuss the Company’s performance on Wednesday afternoon, January 13, at 1:15 PM PST / 4:15 PM EST.
Shareholders and interested parties may access the conference call and webinar by registering at the following link:
https://www2.gotomeeting.com/register/859816195. When you register, you will receive an email from GoToWebinar with a unique access code and audio pin. Please make sure to dial into the call in addition to logging on to your computer.
About Simulations Plus, Inc.
Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development software, which is licensed to and used in the conduct of drug research by pharmaceutical, biotechnology, and drug delivery companies worldwide as well as in the study of environmental toxicology. The Company’s Words+ subsidiary, which provides assistive technology for persons with disabilities, and two retail products, Abbreviate! and FutureLab™, comprise the remainder of the business. Simulations Plus, Inc., is headquartered in Southern California and trades on the NASDAQ Capital Market under the symbol “SLP.” For more information, visit our Web site at www.simulations-plus.com.